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Background
Previously, we employed site-directed mutagenesis to
introduce HIV-1 4E10 and 2F5 epitopes into the corre-
sponding region of a functional HIV-2 envelope glycopro-
teins (AIDS Vaccine 2005, abstract #A210). The resulting
"chimeric" viruses were used to screen HIV-1 infected
human plasma for 4E10 or 2F5-like neutralizing antibod-
ies (Nabs). Among 177 subjects infected with HIV-1 rep-
resenting ten different subtypes or circulating
recombinant forms, none had significant Nab titers
directed toward these epitopes.
Materials and methods
Here, we tested the same HIV-1 positive plasma speci-
mens for neutralizing activity against chimeric HIV-2
viruses in which we substituted the complete 25 amino
acid HIV-1 MPER (designated clone C1) or non-overlap-
ping amino-terminal or carboxy-terminal portions of it
(designated C3 and C4, respectively) using a single-cycle
infectivity assay (Nature 422:307, 2003).
Results
HIV-2 viruses containing the C1, C3 or C4 MPER, and the
parental virus HIV-2/7312A, were infectious and equally
susceptible to neutralization by T1249, sCD4, the anti-
HIV-2 Env mAb 1.7A, and polyclonal anti-HIV-2 antibod-
ies. This result demonstrates that none of the chimeric
HIV-2 viruses was "globally sensitive" to neutralization.
Surprisingly, 60 out of 165 (36%) of HIV-1 plasmas tested
contained MPER specific Nabs. IC50 titers ranged from
0.0005–0.02 (mean 0.006; median 0.004; standard devi-
ation 0.004). Anti-MPER Nab reactivities were mapped to
C3 (6 subjects) or C4 (14 subjects) regions of the HIV-1
MPER or to epitopes spanning them (13 subjects). None
of the 60 subjects with Nabs to C1, C3, or C4 had antibod-
ies that neutralized HIV-2 viruses containing 2F5 or 4E10
epitopes only.
Conclusion
These results indicate that the MPER of HIV-1 elicits Nab
responses in a substantial proportion of infected patients
and that the epitopes recognized by these Nabs are dis-
tinct from those recognized by 4E10 or 2F5.
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